Explore the latest in osteoporosis, including recent guidelines for and advances in screening, management, and prevention of the disorder.
This trial protocol of the Norwegian Capture the Fracture Initiative (NoFRACT) intends to use registry data from Norway and a stepped wedge cluster design to investigate the effect of a standardized intervention program on the rate of subsequent fracture among patients with a fragility fracture.
This cohort study reports osteoporosis medication initiation rates among adults with hip fracture and estimates the association with risk reduction in subsequent nonvertebral fractures.
This JAMA Patient Page describes the US Preventive Services Task Force recommendations on screening for osteoporosis to prevent fractures.
This 2018 Recommendation Statement from the US Preventive Services Task Force recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older (B recommendation) and in postmenopausal women younger than 65 years at increased risk of osteoporosis (B recommendation), and concludes that current evidence is insufficient to assess the benefits and harms of screening to prevent osteoporotic fractures in men (I statement).
This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on osteoporosis screening summarizes published evidence on the benefits and harms of screening and treatment to prevent osteoporotic fractures in adults 40 years and older.
This study examines the frequency of steroid use for acute respiratory tract infections in Louisiana and nationally, and factors associated with this clinical practice.
This case-control study uses a large health care claims database to investigate whether there is an association between hypovitaminosis D and an increased risk of uveitis in adults who received a diagnosis of noninfectious uveitis.
This 2018 US Preventive Services Task Force guideline concludes that current evidence is insufficient to assess the balance of benefits and harms of vitamin D and calcium supplementation, alone or combined, for primary prevention of fractures in community-dwelling, asymptomatic men and premenopausal women (I statement) and recommends against daily supplementation for primary prevention of fractures in community-dwelling, postmenopausal women (D recommendation).
This JAMA Clinical Guidelines Synopsis summarizes the 2017 American College of Physicians’ guideline on treatment of osteoporosis.
This study evaluates the relationship between bone mineral density and intracranial aneurysm.
This meta-analysis summarizes the effects of calcium, vitamin D, or combined calcium and vitamin D supplements on fracture incidence among community-dwelling older adults.
This systematic review to support the 2017 update of the US Preventive Services Task Force Recommendation Statement on use of hormone therapy summarizes published evidence on the benefits and harms of hormone therapy for primary prevention of chronic conditions in postmenopausal women.
This cohort study uses health administrative databases in Ontario, Canada, to investigate the optimal timing of hip fracture surgery after which patients’ risk of complications increase.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: